Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7MXI

IgE-Fc in complex with DARPins E2_79 and E3_53

Summary for 7MXI
Entry DOI10.2210/pdb7mxi/pdb
DescriptorIgE Fc, DARPin E3_53, Anti-IgE Inhibitor E2_79, ... (5 entities in total)
Functional Keywordsige, darpin, allergy, inhibitor, immune system
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains6
Total formula weight125455.18
Authors
Pennington, L.F.,Jardetzky, T.J. (deposition date: 2021-05-19, release date: 2021-07-28, Last modification date: 2024-10-23)
Primary citationPennington, L.F.,Gasser, P.,Brigger, D.,Guntern, P.,Eggel, A.,Jardetzky, T.S.
Structure-guided design of ultrapotent disruptive IgE inhibitors to rapidly terminate acute allergic reactions.
J.Allergy Clin.Immunol., 148:1049-1060, 2021
Cited by
PubMed Abstract: Anaphylaxis represents one of the most severe and fatal forms of allergic reactions. Like most other allergies, it is caused by activation of basophils and mast cells by allergen-mediated cross-linking of IgE bound to its high-affinity receptor, FcεRI, on the cell surface. The systemic release of soluble mediators induces an inflammatory cascade, rapidly causing symptoms with peak severity in minutes to hours after allergen exposure. Primary treatment for anaphylaxis consists of immediate intramuscular administration of adrenaline.
PubMed: 33991582
DOI: 10.1016/j.jaci.2021.03.050
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.8 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon